R&D

Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial

https://pharmaphorum.com/news/gileads-covid-19-drug-veklury-falls-short-in-whos-global-trial/

New CEO Mortazavi takes UK biotech e-therapeutics into gene silencing

https://pharmaphorum.com/news/new-ceo-mortazavi-takes-e-therapeutics-into-gene-silencing/

J+D FORECASTING LAUNCHES INTELLIGENT DATA

https://pharmaphorum.com/partner-content/jd-forecasting-launches-intelligent-data/

Axovant pushes on with Parkinson’s gene therapy, despite investor cynicism

https://pharmaphorum.com/news/axovant-pushes-on-with-parkinsons-gene-therapy/

AI-ML Drug Discovery & Development Summit 2021

https://pharmaphorum.com/events/ai-ml-drug-discovery-development-summit-2021/

Roche pays $200m for Vaccibody’s cancer vaccine drug

https://pharmaphorum.com/news/roche-pays-200m-for-vaccibodys/

Cellular Immunotherapies for Solid Tumors Summit

https://pharmaphorum.com/events/cellular-immunotherapies-for-solid-tumors-summit/

CAR-T Beyond Oncology Digital Summit

https://pharmaphorum.com/events/car-t-beyond-oncology-digital-summit/

PureTech’s Vedanta Biosciences gets federal funding for C. Diff. microbiome therapy

https://pharmaphorum.com/news/puretechs-vedanta-biosciences-gets-federal-funding-for-c-diff-microbiome-therapy/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search